The Effect of Physostigmine on Cognitive Functioning in the Immediate Period After Sedation for Colonoscopy

• Status: Unknown status
• Trial end date: 2011-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether the administration of physostigmine in combination with sedation for colonoscopy can minimize the cognitive decline at the time of hospital discharge

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rabin Medical Center
• Treatments: Physostigmine

Criteria

Inclusion Criteria:

• Over18 years old

• ASA I-III

• Fluency in Hebrew, Russian, or Arabic

• Absence of serious hearing or vision impairment

Exclusion Criteria:

• History of head trauma, neurological diseases, alcoholism, drug abuse, consumption of psychotropic drugs or antidepressants

• Heart failure (NYHA > 3)

• Liver failure

• Respiratory problems (asthma, etc.)